Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Midterm Results of Aortic Valve Replacement Using Tissue Valve

조직판막을 이용한 대동맥판막치환술의 중기성적

  • Moon, Duk-Hwan (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Jae-Won (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Yun-Seok (Department of Thoracic and Cardiovascular Surgery, The Army Armed Forces Hampyung Hospital) ;
  • Cho, Won-Chul (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jung, Sung-Ho (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choo, Suk-Jung (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Chung, Cheol-Hyun (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • 문덕환 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 이재원 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 김윤석 (국군함평병원 흉부외과) ;
  • 조원철 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 정성호 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 주석중 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 정철현 (울산대학교 의과대학 서울아산병원 흉부외과학교실)
  • Received : 2010.08.23
  • Accepted : 2010.11.22
  • Published : 2010.12.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The durability of the tissue valve is important in choice between a mechanical valve and a tissue valve in cardiac surgery. We studied the mid-term results of tissue valve in the aortic position. Material and Method: The subjects were 380 patients who had undergone aortic prosthesis replacement between May 1990 and March 2009. We retrospectively analyzed hospital and outpatient records: the mean age was $69{\pm}9$ years; the male to female ratio was 227 : 162; and the mean follow-up duration was $46.7{\pm}40.8$ months (range 0~196 months). Result: 389 surgical cases in total had been taken with 380 patients. Early death occurred in 15 patients (3.9%). Overall survival rate at 1, 5 and 10 years were 92.3%, 78.1% and 54.2% respectively. Freedom from reoperation at 1, 5 and 10 years were 98.4%, 97.1% and 91.7% respectively. Freedom from structural valvular deterioration at 1, 5 and 10 years were 96.1%, 92.3% and 88.0% respectively. In the multivariate analysis of preoperative risk factors, young age (p<0.001) was significant risk factor for reoperation. High peak velocity in the postoperative period (p=0.034) and young age (p=0.029) were significant risk factors for structural valvular deterioration. Old age (p=0.001), long bypass time (p=0.035), concomitant coronary artery bypass graft surgery (p=0.003) and preoperative low left ventricular ejection fraction (p=0.003) were significant factors for early mortality. Preoperative estimated glomerular filtration rate (< 60 mL/min) (p=0.025) and persistent left ventricular hypertrophy (p=0.032) were the risk factors for late mortality. Conclusion: This study showed that the freedom from reoperation and the freedom from structural valvular deterioration in aortic tissue valve replacement were acceptable. It will be necessary to conduct further studies with long-term follow-up and more patients.

배경: 조직판막의 내구성은 심장 판막 수술에서 기계판막과 조직판막을 선택하는 중요한 기준이 된다. 본 연구는 조직판막이 사용된 대동맥판막치환술의 중기성적을 분석해 보았다. 대상 및 방법: 이 연구는 1990년 3월부터 2009년 3월까지 조직판막을 이용하여 대동맥판막치환술을 시행한 380명의 환자들을 대상으로 하였다. 술 후 평균 관찰 기간은 $46.7{\pm}40.8$월(0~196개월)이었으며 외래 경과 기록과 의무기록을 통하여 후향적으로 분석하였다. 결과: 총 380명의 환자에서 389예의 수술이 시행되었으며 환자들의 평균 연령은 $69{\pm}9$세, 남녀 비는 227 : 162였다. 조기 사망은 15명 (3.9%)이었다. 1년, 5년, 10년 생존율은 92.3%, 78.1%, 54.2%였다. 재수술의 l년, 5년, 10년 회피율(Freedom from reoperation)은 98.4%, 97.1%, 91.7%였으며 구조적 판막 손상 1년, 5년, 10년의 회피율(Freedom from structural valvular deterioration)은 96.1%, 92.3%, 88.0%였다. 수술 전 위험인자의 다변량 분석에서 젊은 나이 (p<0.001)가 재수술의 위험인자였으며 수술 후 판막 부하 최고속도(p=0.034)와 젊은 나이(p=0.029)가 구조적 판막 손상의 위험인자였다. 고령(p=0.001), 장시간의 심폐기사용(long bypass time) (p=0.035), 관상동맥 우회술을 동시에 실시한 경우(concomitant CABG) (p=0.003), 술 전 중등도 이상의 좌심실 기 능부전(Left ventricular ejection fraction, LVEF<40%) (p=0.003)이 조기 사망의 위험인자였으며 술 전 신기능저하(estimated glomerular filtration rate, eGFR<60 mL/min) (p=0.025)와 지속적인 좌심실비대(persistent left ventricular hypertrophy, LVH) (p=0.032)가 만기 사망의 위험인자였다. 결론: 이 연구를 통해 조직판막을 이용한 대동맥판막치환술은 재수술과 구조적 판막 손상 회피율 등의 측면에서 만족할 만하다고 할 수 있으며, 향후 더 많은 환자에서 보다 장기적인 연구가 필요할 것으로 생각된다.

Keywords

References

  1. Edmunds Jr LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity abd mortality after cardiac valvular operations. Ad hocliaison committee for standardizing definitions of prosthetic heart valve morbidity of the American association for thoracic surgery and the society of thoracic surgeons. J Thorac Cardiovasc Surg 1996;112:708-11. https://doi.org/10.1016/S0022-5223(96)70055-7
  2. Jameison WR, Monro AI, Miyagishima RT, Allen P, Burr LH, Tyers GF. Carpentier-Edwards standard porcine bioprosthesis: clinical performance to seventeen years. Ann Thorac Surg 1995;60:999-1006. https://doi.org/10.1016/0003-4975(95)00692-E
  3. Banbury MK, Cosgrove DM 3rd, White JA, Blackstone EH, Frater RW, Okies JE. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2001;72:753-7. https://doi.org/10.1016/S0003-4975(01)02992-7
  4. Becker RM, Strom J, Frishman W, et al. Hemodynamic performance of the Ionescu-Shiley valve prosthesis. J Thorac Cardiovasc Surg 1980;80:613-20.
  5. Gao G, Wu YX, Grunkemeier GL, Furnary AP, Starr A. Durability of pericardial versus porcine aortic valves. J Am Coll Cardiol 2004;44:384-8. https://doi.org/10.1016/j.jacc.2004.01.053
  6. Rashimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 2003;41:893-904. https://doi.org/10.1016/S0735-1097(02)02965-0
  7. David TE, Armstrong S, Sun Z. The Hancock II bioprosthesis at 12 years. Ann Thorac Surg 1998;66:95-8. https://doi.org/10.1016/S0003-4975(98)00318-X
  8. Corbineau H, Verhoye JP, Tauran A, Langanay T, Menestret P, Leguerrier A. Medtronic intact porcine bioprosthesis in the aortic position: 13-year results. J Heart Valve Dis 2002;11:537-41.
  9. Jamieson WR, Janusz MT, MacNab J, Henderson C. Hemodynamic comparison of second- and third-generation stented bioprostheses in aortic valve replacement. Ann Thorac Surg 2001;71:282-4. https://doi.org/10.1016/S0003-4975(01)02540-1
  10. Pellerin M, Mihaileanu S, Couetil JP, et al. Carpentier- Edwards pericardial bioprosthesis in aortic position: long- term follow-up 1980 to 1994. Ann Thorac Surg 1995;60:292-5. https://doi.org/10.1016/0003-4975(95)00368-U
  11. Relland J, Perier P, Lecointe B. The third generation Carpentier-Edwards bioprosthesis: early results. J Am Coll Cardiol 1985;6:1149-54. https://doi.org/10.1016/S0735-1097(85)80323-5
  12. Schelbert EB, Vaughan-Sarrazin MS, Welke KF, Rosenthal GE. Valve type and long-term outcomes after aortic valve replacement in older patients. Heart 2008;94:1181-8. https://doi.org/10.1136/hrt.2007.127506
  13. Daenen W, Noyez L, Lesaffre E, Groffin Y, Stalpaert G. The Ionescu-Shiley pericardial valve: results in 473 patients. Ann Thorac Surg 1998;46:536-41.
  14. Jamieson WR, Janusz MT, Burr LH, Ling H, Miyagishima RT, Germann E. Carpentier-Edwards supraannular porcine bioprosthesis: second-generation prosthesis in aortic valve replacement. Ann Thorac Surg 2001;71:224-7. https://doi.org/10.1016/S0003-4975(01)02549-8
  15. Cohn LH, Collins JJ Jr, Rizzo RJ, et al. Twenty-tear follow up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg 1998;66:30-4. https://doi.org/10.1016/S0003-4975(98)01105-9
  16. Silberman S, Oren A, Dotan M, et al. Aortic valve replacement: choice between mechanical valves and bioprostheses. J Card Surg 2008;23:299-306. https://doi.org/10.1111/j.1540-8191.2008.00580.x
  17. Girard SE, Miller FA, Orszulak TA, et al. Reopeation for prosthetic aortic valve obstruction in the era of echocardiography: Trends in diagnostic testing and comparison with surgical findings. J Am Coll Cardiol 2001;37:579-84. https://doi.org/10.1016/S0735-1097(00)01113-X